Cover Image

Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin-angiotensin system inhibitors in type 2 diabetic patients with albuminuria

Objective:Concomitant treatment with angiotensin-converting enzyme (ACE) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors is increasingly common. Pharmacological studies have suggested a potential adverse drug interaction between ACE inhibitors and DPP-4 inhibitors resulting in unfavorable h

Saved in:
Bibliographic Details
Main Authors: Cooper, Mark (Author) , Perkovic, Vlado (Author) , Groop, Per-Henrik (Author) , Hocher, Berthold (Author) , Hehnke, Uwe (Author) , Meinicke, Thomas (Author) , Koitka-Weber, Audrey (Author) , Walt, Sandra van der (Author) , Eynatten, Maximilian von (Author)
Format: Article (Journal)
Language:English
Published: [June 2019]
In: Journal of hypertension
Year: 2019, Volume: 37, Issue: 6, Pages: 1294-1300
ISSN:1473-5598
DOI:10.1097/HJH.0000000000002032
Online Access:Verlag, Volltext: https://doi.org/10.1097/HJH.0000000000002032
Get full text
Author Notes:Mark Cooper, Vlado Perkovic, Per-Henrik Groop, Berthold Hocher, Uwe Hehnke, Thomas Meinicke, Audrey Koitka-Weber, Sandra van der Walt, and Maximilian von Eynatten
Description
Summary:Objective:Concomitant treatment with angiotensin-converting enzyme (ACE) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors is increasingly common. Pharmacological studies have suggested a potential adverse drug interaction between ACE inhibitors and DPP-4 inhibitors resulting in unfavorable h
Item Description:Gesehen am 13.06.2019
Physical Description:Online Resource
ISSN:1473-5598
DOI:10.1097/HJH.0000000000002032

Similar Items